Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations

Benzer Materyaller

• Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis.
  Yazar:: Mehta, R T, ve diğerleri
  Baskı/Yayın Bilgisi: (1987)
• In Vitro Activity of Nystatin Compared with Those of Liposomal Nystatin, Amphotericin B, and Fluconazole against Clinical Candida Isolates
  Yazar:: Arikan, Sevtap, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.
  Yazar:: Hopfer, R L, ve diğerleri
  Baskı/Yayın Bilgisi: (1984)
• Comparison of In Vitro Activity of Liposomal Nystatin against Aspergillus Species with Those of Nystatin, Amphotericin B (AB) Deoxycholate, AB Colloidal Dispersion, Liposomal AB, AB Lipid Complex, and Itraconazole
  Yazar:: Oakley, Karen L., ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• In Vitro Activities of Free and Lipid Formulations of Amphotericin B and Nystatin against Clinical Isolates of Coccidioides immitis at Various Saprobic Stages
  Yazar:: González, Gloria M., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)